These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 30901422)
1. Naval Health Research Center Surveillance for Meningococcal Disease. Broderick M; Myers C Mil Med; 2019 Mar; 184(Suppl 1):102-105. PubMed ID: 30901422 [TBL] [Abstract][Full Text] [Related]
2. Surveillance snapshot: cases of service member meningococcal disease reported to the Naval Health Research Center Laboratory-based Meningococcal Disease Surveillance Program, 2006-2014. Broderick MP MSMR; 2014 Jul; 21(7):18. PubMed ID: 25080333 [No Abstract] [Full Text] [Related]
3. Trends in meningococcal disease in the United States military, 1971-2010. Broderick MP; Faix DJ; Hansen CJ; Blair PJ Emerg Infect Dis; 2012 Sep; 18(9):1430-7. PubMed ID: 22932005 [TBL] [Abstract][Full Text] [Related]
4. Preventive effect of meningococcal vaccination in Israeli military recruits. Mimouni D; Bar-Zeev Y; Huerta M; Balicer RD; Grotto I; Ankol O Am J Infect Control; 2010 Feb; 38(1):56-8. PubMed ID: 19709780 [TBL] [Abstract][Full Text] [Related]
5. Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy. Bechini A; Levi M; Boccalini S; Tiscione E; Balocchini E; Canessa C; Azzari C; Bonanni P Vaccine; 2012 Oct; 30(45):6396-401. PubMed ID: 22921931 [TBL] [Abstract][Full Text] [Related]
6. Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroup-specific components, 1964-1998. Brundage JF; Ryan MA; Feighner BH; Erdtmann FJ Clin Infect Dis; 2002 Dec; 35(11):1376-81. PubMed ID: 12439801 [TBL] [Abstract][Full Text] [Related]
7. Invasive meningococcal disease epidemiology and control measures: a framework for evaluation. Caro JJ; Möller J; Getsios D; Coudeville L; El-Hadi W; Chevat C; Nguyen VH; Caro I BMC Public Health; 2007 Jun; 7():130. PubMed ID: 17603880 [TBL] [Abstract][Full Text] [Related]
8. Changes in meningococcal C epidemiology and vaccine effectiveness after vaccine introduction and schedule modification. Garrido-Estepa M; León-Gómez I; Herruzo R; Cano R Vaccine; 2014 May; 32(22):2604-9. PubMed ID: 24662700 [TBL] [Abstract][Full Text] [Related]
9. Enhanced surveillance scheme for suspected meningococcal disease in five regional health authorities in England: 1998. Davison KL; Crowcroft NS; Ramsay ME; Begg NT; Kaczmarski EB; Stuart JM; White JM; Orr H; Commun Dis Public Health; 2002 Sep; 5(3):205-12. PubMed ID: 12434690 [TBL] [Abstract][Full Text] [Related]
10. Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines. Ladhani SN; Flood JS; Ramsay ME; Campbell H; Gray SJ; Kaczmarski EB; Mallard RH; Guiver M; Newbold LS; Borrow R Vaccine; 2012 May; 30(24):3710-6. PubMed ID: 22429756 [TBL] [Abstract][Full Text] [Related]
11. Surveillance of invasive meningococcal disease in the Czech Republic. Kriz P Euro Surveill; 2004 Nov; 9(11):37-9. PubMed ID: 15591689 [TBL] [Abstract][Full Text] [Related]
12. Epidemiology of invasive meningococcal disease in the Netherlands, 1960-2012: an analysis of national surveillance data. Bijlsma MW; Bekker V; Brouwer MC; Spanjaard L; van de Beek D; van der Ende A Lancet Infect Dis; 2014 Sep; 14(9):805-12. PubMed ID: 25104306 [TBL] [Abstract][Full Text] [Related]
13. Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment. Wormsbecker AE; Wong K; Jamieson FB; Crowcroft NS; Deeks SL Vaccine; 2015 Oct; 33(42):5678-5683. PubMed ID: 26299749 [TBL] [Abstract][Full Text] [Related]
14. Impact of meningococcal C conjugate vaccination programs with and without catch-up campaigns in adolescents: Lessons learned from Bahia, Brazil. Evellyn do Macedo L; Ferreira VM; Feitosa CA; Nunes AMPB; Campos LC; Sáfadi MAP Hum Vaccin Immunother; 2018 May; 14(5):1131-1137. PubMed ID: 29236585 [TBL] [Abstract][Full Text] [Related]
15. Surveillance of invasive meningococcal disease in Queensland, 2002. Pugh RE; Smith H; Young M Commun Dis Intell Q Rep; 2003; 27(3):342-51. PubMed ID: 14510059 [TBL] [Abstract][Full Text] [Related]
16. Comparison of meningococcal disease surveillance systems - United States, 2005-2008. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2012 May; 61(17):306-8. PubMed ID: 22552207 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study. Parikh SR; Andrews NJ; Beebeejaun K; Campbell H; Ribeiro S; Ward C; White JM; Borrow R; Ramsay ME; Ladhani SN Lancet; 2016 Dec; 388(10061):2775-2782. PubMed ID: 28100432 [TBL] [Abstract][Full Text] [Related]
18. Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges. Mustapha MM; Harrison LH Hum Vaccin Immunother; 2018 May; 14(5):1107-1115. PubMed ID: 29211624 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States. Shepard CW; Ortega-Sanchez IR; Scott RD; Rosenstein NE; Pediatrics; 2005 May; 115(5):1220-32. PubMed ID: 15867028 [TBL] [Abstract][Full Text] [Related]
20. Invasive meningococcal disease in adolescents and young adults. Harrison LH; Pass MA; Mendelsohn AB; Egri M; Rosenstein NE; Bustamante A; Razeq J; Roche JC JAMA; 2001 Aug; 286(6):694-9. PubMed ID: 11495619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]